ADMS - アダマス・ファ―マシュ―ティカルズ (Adamas Pharmaceuticals Inc.)

ADMSのニュース

   ADMS ROSEN, A TOP LAW FIRM, Reminds Adamas Pharmaceuticals, Inc. Investors of Important February 10th Deadline in Securities Class Action – ADMS  2020/01/04 16:01:01 MarketScreener
NEW YORK, Jan. 04, 2020 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Adamas Pharmaceuticals, Inc. between August 8, 2017 and September 30,…
   Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Adamas Pharmaceuticals, Inc.  2019/12/20 17:00:00 Business Wire
LOS ANGELES--(BUSINESS WIRE)---- $ADMS--Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Adamas Pharmaceuticals, Inc.
   INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Adamas Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm  2019/12/17 23:18:00 Business Wire
LOS ANGELES--(BUSINESS WIRE)---- $ADMS #ADMS--INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Adamas Pharmaceuticals, Inc.
   Adamas drug to help MS patients walk does not show expected clinical benefit  2019/12/17 14:11:44 Channel NewsAsia
REUTERS: Adamas Pharmaceuticals Inc said on Tuesday its drug to treat walking impairment in patients with multiple sclerosis did not show the …
   Is Adamas Pharmaceuticals Inc (ADMS) A Good Stock To Buy ?  2019/12/16 10:45:55 Yahoo Finance
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the second quarter. One of these stocks was Adamas Pharmaceuticals Inc (NASDAQ:ADMS). Is Adamas Pharmaceuticals
   Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Adamas Pharmaceuticals, Inc.  2019/12/20 17:00:00 Business Wire
LOS ANGELES--(BUSINESS WIRE)---- $ADMS--Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Adamas Pharmaceuticals, Inc.
   INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Adamas Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm  2019/12/17 23:18:00 Business Wire
LOS ANGELES--(BUSINESS WIRE)---- $ADMS #ADMS--INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Adamas Pharmaceuticals, Inc.
   Adamas drug to help MS patients walk does not show expected clinical benefit  2019/12/17 14:11:44 Channel NewsAsia
REUTERS: Adamas Pharmaceuticals Inc said on Tuesday its drug to treat walking impairment in patients with multiple sclerosis did not show the …
   Is Adamas Pharmaceuticals Inc (ADMS) A Good Stock To Buy ?  2019/12/16 10:45:55 Yahoo Finance
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the second quarter. One of these stocks was Adamas Pharmaceuticals Inc (NASDAQ:ADMS). Is Adamas Pharmaceuticals
   ADMS LOSS NOTICE ALERT: TOP RANKED Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Adamas Pharmaceuticals, Inc. - ADMS | MarketScreener  2019/12/14 20:16:03 MarketScreener
NEW YORK, Dec. 14, 2019 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Adamas… | December 14, 2019
  Adamas Pharmaceuticals Inc(ADMS)は良い在庫ですか?」 Is Adamas Pharmaceuticals Inc (ADMS) A Good Stock To Buy ?  2019/12/16 10:45:55 Yahoo Finance
「第1四半期の13Fファイリングの後に、世界で最高のマネーマネージャーの一部が第2四半期に投資または売却することを好む株式を見てみましょう。これらの株式の1つはアダマスでしたPharmaceuticals Inc(NASDAQ:ADMS)はIs Adamas Pharmaceuticalsです
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the second quarter. One of these stocks was Adamas Pharmaceuticals Inc (NASDAQ:ADMS). Is Adamas Pharmaceuticals
   ADMS LOSS NOTICE ALERT: TOP RANKED Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Adamas Pharmaceuticals, Inc. - ADMS | MarketScreener  2019/12/14 20:16:03 MarketScreener
NEW YORK, Dec. 14, 2019 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Adamas… | December 14, 2019
   Adamas Pharmaceuticals : Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Adamas Pharmaceuticals, Inc. Investors | MarketScreener  2019/12/13 21:01:03 MarketScreener
Glancy Prongay & Murray LLP , a national investors rights law firm, announces that a class action lawsuit has been filed on behalf of investors that acquired Adamas Pharmaceuticals, Inc. … | December 13, 2019
   Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Adamas Pharmaceuticals, Inc. Investors  2019/12/13 21:00:00 Business Wire
LOS ANGELES--(BUSINESS WIRE)---- $ADMS--Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Adamas Pharmaceuticals, Inc. Investors
   Shareholder Alert: Robbins LLP Announces Adamas Pharmaceuticals, Inc. (ADMS) Sued for Misleading Shareholders  2019/12/13 01:43:00 Business Wire
SAN DIEGO & EMERYVILLE, Calif.--(BUSINESS WIRE)---- $ADMS #ClassAction--Shareholder rights law firm Robbins LLP announces that a purchaser of Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS) filed a class action complaint for alleged violations of the Securities Exchange Act of 1934 between August 8, 2017 and September 30, 2019. Adamas is a commercial stage pharmaceutical company that specializes in developing drug treatment therapies for chronic neurologic disorders. Adamas' primary product is GOCOVRI. If you suffered a

calendar